Evidence map›Paper›PMID 33505511›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2021

The Antitumour Effect of

Fangqin Yu, Lele Zhang, Runsheng Ma, Chenguang Liu, Qingduan Wang, Detao Yin

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Efficacy and safety ofFrontiers in pharmacology · 2025
    Pooled it
  2. Article
  3. Article
  4. AnHeliyon · 2022
    Article
  5. Article
  6. Review
  7. Water-ExtractedFrontiers in pharmacology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Fangqin YuDepartment of Thyroid Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.
Lele ZhangDepartment of Thyroid Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.ORCID https://orcid.org/0000-0002-8400-5188
Runsheng MaDepartment of Thyroid Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.
Chenguang LiuDepartment of Thyroid Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.
Qingduan WangZhengzhou University, Academy of Medical and Pharmaceutical Sciences, Henan Key Laboratory for Pharmacology of Liver Diseases, Zhengzhou, China.
Detao YinDepartment of Thyroid Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.ORCID https://orcid.org/0000-0002-4349-6857
First Affiliated Hospital of Zhengzhou University · CNZhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33505511
PMCPMC7811421
OpenAlexW3120818523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.